ArticleWellcome open research2020

Interleukin-2 Therapy of Autoimmunity in Diabetes (ITAD): a phase 2, multicentre, double-blind, randomized, placebo-controlled trial.

M Loredana Marcovecchio et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.